Ownership history in Future Fund LLC · 11 quarters on record
This page tracks every 13F SEC filing in which Future Fund LLC reported a position in HALOZYME THERAPEUTICS INC (HALO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 83,030 | +20,581 | +33.0% | 1.77% | $5.6M | $67.30 |
| 2025 Q3 | ADDED | 62,449 | +6,757 | +12.1% | 1.62% | $4.6M | $73.34 |
| 2025 Q2 | ADDED | 55,692 | +21,873 | +64.7% | 1.29% | $2.9M | $52.02 |
| 2025 Q1 | ADDED | 33,819 | +16,223 | +92.2% | 2.77% | $2.2M | $63.81 |
| 2024 Q4 | ADDED | 17,596 | +6,500 | +58.6% | 2.40% | $841K | $47.81 |
| 2024 Q3 | REDUCED | 11,096 | -25,199 | -69.4% | 1.83% | $634K | $57.24 |
| 2024 Q2 | ADDED | 36,295 | +24,020 | +195.7% | 4.74% | $1.9M | $52.36 |
| 2024 Q1 | ADDED | 12,275 | +5,109 | +71.3% | 4.05% | $499K | $40.68 |
| 2023 Q4 | REDUCED | 7,166 | -1,400 | -16.3% | 0.73% | $265K | $36.96 |
| 2023 Q3 | REDUCED | 8,566 | -596 | -6.5% | 0.91% | $327K | $38.20 |
As of 2025 Q4 — sorted by position size